Vanda Pharmaceuticals (VNDA) Return on Equity [ROE] (2011 - 2026)
Vanda Pharmaceuticals' Return on Equity [ROE] came in at -109.75% for Q2 2026, down 96.34 percentage points from -13.41% a year earlier and down 30.94 percentage points from the prior quarter.
Powered by 
Analysis
Vanda Pharmaceuticals (VNDA) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2025, Vanda Pharmaceuticals' Return on Equity [ROE] was -50.93%, down 47.44 percentage points from FY2024.
- Return on Equity [ROE] has declined in each of the last four years, with a five-year change of -56.33 percentage points (FY2020 to FY2025).
- Going back by year, Return on Equity [ROE] was -3.49% in FY2024 (-3.96 pp), 0.47% in FY2023 (-0.75 pp), 1.22% in FY2022 (-5.70 pp) and 6.92% in FY2021 (+1.52 pp).
- The Q2 2026 figure represents the lowest quarterly Return on Equity [ROE] since Q3 2014.
- Year-over-year, Return on Equity [ROE] has declined for 11 consecutive quarters, with an average year-over-year change of -32.70 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q3 2021 (a gain of 2.60 percentage points), and the weakest in Q2 2026 (a drop of 96.34 percentage points).
- Business Quant data shows VNDA's Return on Equity [ROE] at -78.81% (Q1 2026), -55.59% (Q4 2025) and -17.67% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Vanda Pharmaceuticals | 296.83 Mn | -633.11 Mn | 46.97 Mn | -109.75% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -109.75% |
| Mar 31, 2026 | -78.81% |
| Dec 31, 2025 | -55.59% |
| Sep 30, 2025 | -17.67% |
| Jun 30, 2025 | -13.41% |
| Mar 31, 2025 | -8.42% |
| Dec 31, 2024 | -3.50% |
| Sep 30, 2024 | -3.02% |
| Jun 30, 2024 | -2.00% |
| Mar 31, 2024 | -0.89% |
| Dec 31, 2023 | 0.46% |
| Sep 30, 2023 | 2.18% |
| Jun 30, 2023 | 2.76% |
| Mar 31, 2023 | 3.00% |
| Dec 31, 2022 | 1.21% |
| Sep 30, 2022 | 1.27% |
| Jun 30, 2022 | 2.17% |
| Mar 31, 2022 | 3.57% |
| Dec 31, 2021 | 6.62% |
| Sep 30, 2021 | 7.01% |
API Access
Vanda Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=VNDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "VNDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=VNDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();